Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NovoCure Ltd | Chief Operating Officer | Ordinary Shares | 252K | $3.09M | $12.24 | Jun 28, 2024 | Direct |
NovoCure Ltd | Chief Operating Officer | Stock Options (Right to buy) | 95K | $2.17M | $22.82 | Jun 5, 2024 | The 2020 Groenhuysen Annuity Trust |
OptiNose, Inc. | Director | Stock Option (Right to Buy) | 75K | Jun 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NVCR | NovoCure Ltd | Jun 28, 2024 | 1 | $12.9K | 4 | Aug 6, 2024 | Chief Operating Officer |
OPTN | OptiNose, Inc. | Jun 6, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
NVCR | NovoCure Ltd | Jun 5, 2024 | 2 | $0 | 4 | Jun 7, 2024 | Chief Operating Officer |
NVCR | NovoCure Ltd | Mar 1, 2024 | 2 | -$53.3K | 4 | Mar 5, 2024 | Chief Operating Officer |
NVCR | NovoCure Ltd | Feb 27, 2024 | 4 | $1.9M | 4 | Feb 29, 2024 | Chief Operating Officer |
NVCR | NovoCure Ltd | Sep 1, 2023 | 1 | -$6.41K | 4 | Sep 5, 2023 | Chief Operating Officer |
NVCR | NovoCure Ltd | Jun 30, 2023 | 1 | $12.9K | 4 | Jul 6, 2023 | Chief Operating Officer |
OPTN | OptiNose, Inc. | Jun 8, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
NVCR | NovoCure Ltd | Mar 3, 2023 | 3 | -$1.95M | 4 | Mar 7, 2023 | Chief Operating Officer |
NVCR | NovoCure Ltd | Mar 2, 2023 | 3 | -$91.3K | 4 | Mar 6, 2023 | Chief Operating Officer |
NVCR | NovoCure Ltd | Feb 28, 2023 | 3 | $2.61M | 4 | Mar 2, 2023 | Chief Operating Officer |
NVCR | NovoCure Ltd | Jan 6, 2023 | 1 | $6.36K | 4 | Jan 10, 2023 | Chief Operating Officer |
NVCR | NovoCure Ltd | Sep 2, 2022 | 1 | -$23.4K | 4 | Sep 6, 2022 | Chief Operating Officer |
NVCR | NovoCure Ltd | Jul 5, 2022 | 1 | $12.9K | 4 | Jul 7, 2022 | Chief Operating Officer |
OPTN | OptiNose, Inc. | Jun 8, 2022 | 1 | $0 | 4 | Jun 9, 2022 | Director |
NVCR | NovoCure Ltd | May 5, 2022 | 2 | $0 | 4 | May 9, 2022 | Chief Operating Officer |
NVCR | NovoCure Ltd | Mar 8, 2022 | 1 | -$205K | 4 | Mar 9, 2022 | Chief Operating Officer |
NVCR | NovoCure Ltd | Mar 3, 2022 | 5 | $3.43M | 4 | Mar 7, 2022 | Chief Operating Officer |
NVCR | NovoCure Ltd | Jan 6, 2022 | 1 | $4.79K | 4 | Jan 12, 2022 | Chief Operating Officer |
NVCR | NovoCure Ltd | Sep 2, 2021 | 1 | -$25K | 4 | Sep 7, 2021 | Chief Operating Officer |
NVCR | NovoCure Ltd | Aug 10, 2021 | 2 | $0 | 4 | Aug 12, 2021 | Chief Operating Officer |
NVCR | NovoCure Ltd | Jul 6, 2021 | 1 | $9.05K | 4 | Jul 8, 2021 | Chief Operating Officer |
OPTN | OptiNose, Inc. | Jun 9, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |